SCABIES POLICY DOCUMENT CONTROL: Version: Ratified by: Date ratified: Name of originator/author: Name of responsible committee/individual:
|
|
- Ethelbert Cox
- 5 years ago
- Views:
Transcription
1 SCABIES POLICY DOCUMENT CONTROL: Version: 7 Ratified by: Clinical Quality & Standards Group Date ratified: 4 th August 2015 Name of originator/author: Senior Clinical Nurse Specialist - Infection Prevention and Control Name of responsible committee/individual: Infection Prevention & Control Quality & Standards Committee Date issued: 2 September 2015 Review date: September 2018 Target Audience All Clinical Staff
2 CONTENTS SECTION PAGE NO 1 INTRODUCTION 3 2 PURPOSE Definitions/Explanation of Terms Used 3 3 SCOPE 3 4 RESPONSIBILITIES, ACCOUNTABILITIES AND DUTIES Board of Directors Chief Executive Director of Infection Prevention and Control (DIPC) (Deputy Chief 4 Executive/Director of Nursing) 4.4 Infection Prevention and Control Quality and Standards Committee Infection Control Doctors/Consultant Microbiologists Clinical Nurse Specialists - Infection Prevention & Control Quality & 5 Standards Team 4.7 Consultant Medical Staff/Medical Staff Modern Matrons/Service Managers Chief Pharmacist Staff 6 5 PROCEDURE Scabies information Incubation period Transmission Symptoms Diagnosis Complications of Scabies Treatment of Scabies (see appendix 1 for table Permethrin (Lyclear) First Choice treatment Malathion Aqueous 0.5% Liquid (Derbac M) Ivermectin Management of Additional Treatment Information Additional Information for the Treatment of Children Scabies within a group of patients 9 6 TRAINING IMPLICATIONS 10 7 MONITORING ARRANGEMENTS 10 8 EQUALITY IMPACT ASSESSMENT SCREENING Privacy, Dignity and Respect Mental Capacity Act 11 9 LINKS TO ANY ASSOCIATED DOCUMENTS REFERENCES APPENDICES 12 Appendix 1 List of Scabicides 13 Page 2 of 14
3 1. INTRODUCTION Scabies is a parasitic disease caused by the mite, Scarcopes scabei. Skin to skin contact (direct contact) is the mode of transmission. Hyperkeratotic scabies (also called Norwegian Scabies) is a more infectious variant, which can also be transmitted by fomites. 2. PURPOSE The purpose of this policy is to provide information to staff on the care of patients diagnosed or suspected to have Scabies. The policy content is based on sound infection prevention and control (IPC) principles and national guidance. 2.1 Definitions/Explanation of Terms Used 3. SCOPE Hyperkeratotic adjective - overgrowth and thickening of the outer layer of the skin Fomites - any material, such as bedding or clothing, that may harbour pathogens and therefore convey disease This policy applies to all staff having contact with patients under the care of the Trust, whether in a direct or indirect patient care role regardless of the care environment. Adherence to this policy is the responsibility of all staff employed by the Trust, including agency, locum and bank staff contracted by the Trust. This policy should be read in conjunction with other IPC policies, particularly Hand Hygiene, Standard Infection Prevention and Control Precautions. 4. RESPONSIBILITIES, ACCOUNTABILITIES AND DUTIES All staff working on Trust premises, outreach clinics and community settings including Trust employed staff, contractors, agency and locum staff are responsible for adhering to this policy. 4.1 Board of Directors The Board of Directors are responsible for having policies and procedures in place to support best practice, effective management, service delivery, management of associated risks and meet national and local legislation and/or requirements. 4.2 Chief Executive The Chief Executive is responsible for establishing and maintaining IPC arrangements across the organisation, but delegates the responsibilities to the Trust Board and the Director of Infection Prevention and Control. The Director with the lead responsibility is the Deputy Chief Executive and Lead Nurse. Page 3 of 14
4 4.3 Director of Infection Prevention and Control (DIPC) (Deputy Chief Executive/Director of Nursing) The DIPC acts on legislation, national policies and guidance ensuring effective policies are in place and audited and directly reports to the Chief Executive and the Board of Directors: Any identified cases of infections/alert organisms The organisations performance in relation to Healthcare Associated Infection s (HCAI) and provides regular reports, including an annual report and an annual IPC programme All incidents requiring post infection review (PIR) 4.4 Infection Prevention & Control Quality & Standards Committee (IPCQ&SC) The IPCQ&SC members oversee compliance with international and national standards/targets in relation to the prevention and control of HCAI, including the Health and Social Care Act 2008, NHS Litigation Authority (NHSLA) and the Care Quality Commission (CQC) Fundamental Standards. The main duties of the IPCQ&SC are to oversee key IPC issues in regards to: Policy development and review Audit Education and training compliance Communication with staff, patients and the public Horizon scanning for relevant IPC guidance and documents Monitoring of IPC incidents Ensuring that robust plans for the management of outbreaks of infection are in place and to monitor their effectiveness Reviewing PIR reports in order to identify lessons learnt, develop and monitor action plans Agreeing the annual IPC report and work programme prior to its submission to Clinical Governance Group (CGG) To inform the CGG of clinical risk issues relating to the Trust 4.5 Infection Control Doctors/Consultant Microbiologists Medical microbiologists hosted within the provider acute Trusts are available, through a contractual service level agreement to: Provide expert microbiology advice for the management and treatment of micro-organisms Advise on antibiotic policy/prescribing and challenge inappropriate practices Contribute to the PIR process and attend meetings as required Page 4 of 14
5 4.6 Clinical Nurse Specialists (CNS) Infection Prevention & Control Quality & Standards Team (IPCQ&ST) The IPCQ&ST CNS role is to: Provide expert professional advice and education on the prevention and control of infection to other professionals, multi-disciplinary groups, patients and carers Lead in the investigation of identified cases of infection/alert organisms and conditions Advise on control measures, delegating responsibility to Trust staff as appropriate Give advice on complex issues relating to IPC and report findings to the DIPC Report any breaches in policy compliance through the IR1 system and to the IPCQ&SC 4.7 Consultant Medical Staff/Medical Staff Consultant medical staff are responsible for the supervision of junior medical staff assigned to work with them and all staff must: Ensure compliance with IPC policies Liaise with the Consultant Microbiologist for advice if required Be aware of and comply with antibiotic prescribing guidance Contribute to and participate in relevant meetings as required 4.8 Modern Matrons/Service Managers All Service Managers and Modern Matrons are responsible for: Membership at the IPCQ&SC On-going compliance with this policy within their clinical areas and reporting non-compliance to the DIPC via the IPCQ&SC Reporting all matters relating to IPC to the DIPC Facilitating feedback of information related to surveillance data and identified cases of infection/alert organisms and conditions, including Scabies Reporting confirmed cases of infection/alert organisms and conditions to the IPCQ&ST Reporting any breaches in policy compliance through the IR1 system and to the IPCQ&SC 4.9 Chief Pharmacist The Chief Pharmacist will: Contribute to the PIR process when antibiotics have been prescribed Facilitate and evaluate antibiotic and proton pump inhibitor prescribing Undertake audit as requested by the IPCQ&SC Report findings to Medicines Management Committee and IPCQ&SC Page 5 of 14
6 4.10 Staff All staff must comply with this policy and related guidance. 5. PROCEDURE/IMPLEMENTATION 5.1 Scabies Information There are two types of scabies. These being Classical Scabies, which is found in people with normal immune systems and Hyperkeratotic Scabies (also known as Norwegian Scabies), which is often found in the elderly population or those with suppressed immune systems. In Norwegian Scabies the skin becomes thickened, scaled and crusted due to the large number of mites present and is highly contagious due to the number of mites present in the exfoliating skin scales. The scabies mite is extremely small, with the female measuring 0.4 mm in length and the male 0.2 mm. A scabies infestation starts when a mite burrows under the top layer of the skin. They may occur anywhere on the body and the burrows are usually about 5 mm long. 5.2 Incubation period The incubation period is up to 8 weeks. This extended length of incubation time can make the identification and control of scabies difficult, especially in residential social care settings. 5.3 Transmission Scabies mites are not able to jump or fly. The usual method of transmission is through direct and prolonged periods of contact (10-20 minutes) or intimate skin contact. It's unlikely that scabies will be transmitted through brief physical contact, such as shaking hands or hugging. Classical scabies mites can survive outside the human body for 24 to 36 hours, making infestation by coming into contact with contaminated clothes, towels or bed linen a rare possibility, unless they have been contaminated by the infested individual immediately beforehand. In addition to transmission by direct contact, Hyperkeratotic Scabies is easily transmissible via clothing, towels or bedding due to the large number of mites present in the exfoliating skin scales. Hyperkeratotic Scabies mites can survive outside the human body for up to 7 days as they are able to feed on skin scales in bedding, towels or clothing. 5.4 Symptoms The main symptoms of scabies infection are caused through an allergic response to the presence of the mite. This is thought to be caused by the immune system reacting to the mites and their saliva, eggs and faeces. Severe itching develops, especially at night. It may take four to six weeks Page 6 of 14
7 5.5 Diagnosis before the itching starts, however, if the person has had a previous scabies infection, the immune response is rapid and itching develops in hours to days. A rash may develop consisting of tiny red spots and scratching the rash may cause crusty sores to develop. Scabies is usually diagnosed through the presence of intense itching with a follicular papular rash and the burrow marks of the mite. However, as scabies is spread very easily, it's often possible to make a confident diagnosis if more than one family member has the same symptoms 5.6 Complications of Scabies Repeatedly scratching itchy skin may break the skin's surface which may lead to the development of a secondary skin infection. In this situation clinical review and antibiotic therapy may be required. Scabies has been known to make some pre-existing skin conditions, such as eczema, worse. However, other skin conditions should settle down after the scabies infection has been successfully treated. 5.7 Treatment of Scabies (see appendix 1 for table) Permethrin (Lyclear) First Choice treatment. Permethrin Cream (Lyclear 5%) is currently the agent of choice for the treatment of scabies and also for prophylactic treatment for contacts and can be used in pregnancy Permethrin is licensed for use in children over 2 months of age. It is recommended that medical supervision should be sought before applying to children s skin under 2 years of age. Permethrin is a cream, which should be applied and left for 8-12 hours The treatment requires 2 applications 1 week apart In Hyperkeratotic Scabies more than 2 applications on consecutive days may be required. Advice must be obtained from medical staff/dermatology specialists Avoid contact with eyes due to irritation One tube of Permethrin is usually adequate for an average sized person however in obese patients more tubes will be required This is a vanishing cream and so disappears on application. It should be continuously applied until it remains detectable on the skin surface Page 7 of 14
8 5.7.2 Malathion Aqueous 0.5% Liquid (Derbac M) This medication is a lotion and should be left on the body for 24 hours It should not be used more often than once a week for a maximum of three consecutive weeks Avoid in children less than 6 months of age, seek medical advice Can be used in pregnancy Aqueous preparations are preferable to alcoholic lotions, as they are less of an irritant to the skin and respiratory tract Ivermectin This is an oral medication that is only given on a named patient basis within the UK. The decision to prescribe should only be undertaken after consultation with the Dermatology Department. Topical treatments may also be applied in conjunction with the oral medication being given particularly in Hyperkeratotic Scabies that does not respond to oral topical treatment alone Management and Additional Treatment Information As the incubation period can be up to 8 weeks it is important to consider any person who has had prolonged skin to skin contact within the last 8 weeks, as requiring treatment. Ensure the skin is clean, dry and cool before application. A hot bath should be avoided as evidence suggests this could reduce its efficacy. All members of the affected household should be treated at the same time, as prescribed by their GP, to ensure that individuals do not re-infect one another. Apply the cream or lotion to the scalp, jaw line and all over the body including the genital area. Pay particular attention to the webbed areas of toes and fingers. Occasionally an application to the head may be recommended. Applying the cream at night before going to bed is usually the best time because it can be left on overnight. Healthcare staff applying the cream or lotion should wear disposable gloves and a disposable apron with each individual they are treating. In the case of treatment application/care of patients with Hyperkeratotic Scabies arm protection would be advisable. A second person is necessary when treating oneself, to ensure all the body is covered. Nails should be trimmed and medication applied with cotton wool buds Page 8 of 14
9 underneath the nails and around the nail bed area. If hands are subsequently washed, then further treatment needs to be applied. If any part of the body requires washing/cleaning during the treatment time schedule the cream/lotion will need to be reapplied after each wash e.g. after changing continence products. The treatment should be left on for the manufacturers recommended time period. Remove the treatment by thorough washing of all areas of the skin to which it has been applied. Once the treatment has been applied and washed off, wash all bedding and clothing immediately on a hot wash cycle. In healthcare settings, bedding and clothing should be treated as infected linen and red alginate bags should be used (refer to the Laundry Policy). Itching and rash may persist or even become slightly worse for a few days following treatment due to the continuing presence of dead mites and the dead mites faeces in the skin. Antihistamine medication may be useful in this situation. Exclude from school/workplace until 24 hours after treatment has been started. Prolonged skin to skin contact should be avoided wherever possible until 24 hours after treatment. Notify Public Health England on when there is an outbreak of scabies. An outbreak of infection is defined as the occurrence of two or more related cases of the same infection, or where the number of infections is more than would normally be expected (Wilson, 2001). Seek additional advice from the IPC team if required. A Consultant Dermatologist or Consultant Microbiologist can advise on the choice of agent for treatment Additional Information for the Treatment of Children Children under the age of two may also have mites on the face, neck, scalp, ears and the soles of their feet. It is therefore important to pay particular attention to the head, neck, flexor areas and the soles of the feet. Special care must be taken in the selection of the scabicide. 5.8 Scabies Within A Group Of Patients If there is a single case of scabies within a healthcare setting the patient does not require isolation (except with Hyperkeratotic Scabies due to exfoliating skin scales) and can be left in the usual area whilst being treated. Staff Page 9 of 14
10 should however be extremely vigilant for signs and symptoms of scabies in other patients or clients during the following weeks. If there appears to be more than one case of scabies, diagnosis must be confirmed by a Dermatologist before commencing treatment of patients. Treatment will be carried out in consultation with the IPCQ&ST. The Occupational Health Department should be informed of the situation though staff are to contact their own General Practitioner for advice/treatment. 6. TRAINING IMPLICATIONS There are no specific training needs in relation to this policy, but the following staff will need to be familiar with its contents: All clinical staff having face to face contact with patients and any other individual or group with a responsibility for implementing the contents of this policy. As a Trust policy, all staff need to be aware of the key points that the policy covers. Staff can be made aware through: A number of a variety of means such as; Team Brief Trust wide mail drop Team meetings One to one meetings / Supervision Posters CPD sessions Weekly Newsletter Trust wide Special meetings Group supervision Practice Development Days Local Induction 7. MONITORING ARRANGEMENTS Area for Monitoring How Who by Reported to Frequency Noncompliance to policy Monitor breaches in policy via IR1 reporting system. IPCQ&S CNS IPCQ&SC Bi-monthly 8. EQUALITY IMPACT ASSESSMENT SCREENING The completed Equality Impact Assessment for this Policy has been published on the Equality and Diversity webpage of the RDaSH website click here Page 10 of 14
11 8.1 Privacy, Dignity and Respect The NHS Constitution states that all patients should feel that their privacy and dignity are respected while they are in hospital. High Quality Care for All (2008), Lord Darzi s review of the NHS, identifies the need to organise care around the individual, not just clinically but in terms of dignity and respect. Indicate how this will be met No issues have been identified in relation to this policy. As a consequence the Trust is required to articulate its intent to deliver care with privacy and dignity that treats all service users with respect. Therefore, all procedural documents will be considered, if relevant, to reflect the requirement to treat everyone with privacy, dignity and respect, (when appropriate this should also include how same sex accommodation is provided). 8.2 Mental Capacity Act Central to any aspect of care delivered to adults and young people aged 16 years or over will be the consideration of the individuals capacity to participate in the decision making process. Consequently, no intervention should be carried out without either the individuals informed consent, or the powers included in a legal framework, or by order of the Court Therefore, the Trust is required to make sure that all staff working with individuals who use our service are familiar with the provisions within the Mental Capacity Act. For this reason all procedural documents will be considered, if relevant to reflect the provisions of the Mental Capacity Act 2005 to ensure that the interests of an individual whose capacity is in question can continue to make as many decisions for themselves as possible. Indicate How This Will Be Achieved. All individuals involved in the implementation of this policy should do so in accordance with the Guiding Principles of the Mental Capacity Act (Section 1) 9. LINKS TO ANY ASSOCIATED DOCUMENTS This policy should be read in conjunction with other Trust IPC and relevant clinical policies. All policies can be found in the Clinical Policies section of the intranet 10. REFERENCES British National Formulary and British National Formulary for children. April accessed Chin J. (2002). Control of Communicable Diseases Manual American Public Health Association. Page 11 of 14
12 accessed National Institute for Health and Clinical Excellence (2012) Prevention and control of healthcare associated infections in primary and community care. NICE clinical guideline 139 Prodigy. Quick reference guide issued June Sheffield District Infection Control Team (2003). Sheffield District Control of Infection Guidelines. Unpublished Wilson J. (2006). Infection Control in Clinical Practice. 3 rd ed. Baillere Tindall. London. accessed Accessed APPENDICES Appendix 1 List of Scabicides Page 12 of 14
13 LIST OF SCABICIDES: Appendix 1 First Choice Treatment: Permethrin (Lyclear Dermal Cream) Two applications of treatment are used 7 days apart Drug Age Dose Quantity Notes, Permethrin 5% dermal cream 2 months to 2 year Apply to the whole body, including the scalp, face, neck and ears. Leave on for 8-12 hours or overnight. Wash off. 2 to 11 years Apply to the whole body, including the scalp, face, neck and ears. Leave on for 8-12 hours or overnight. Wash off. Repeat after 7 days. 30g** 30g* Cautions/Contraindications Avoid contact with eyes Do not use on broken or secondarily infected skin Do not use in pregnancy or whilst breast feeding For children under 2 years medical supervision is required 12 years onwards Apply to the whole body, including the scalp, face, neck and ears. Leave on for 8-12 hours or overnight. Wash off. Repeat after 7 days. 60g* (may be required) *Two 30g tubes may be required for each application for an adult. For children up to the age of 2 years, one eighth to one quarter of a tube should be enough for each application. Children between 2 and 6 years need about a quarter of a tube per application, and children between 6 and 12 years need about half a tube per application. **A single application is usually sufficient for children under 2 years of age. Page 13 of 14
14 Second Choice Treatment: Malathion (Derbac M) Two applications of treatment are used 7 days apart Drug Age Dose Quantity Notes, Cautions/Contraindications 6 months to 1 Apply to the whole body, including the scalp, face, 100ml* year neck and ears. Malathion 0.5% aqueous liquid 2 years onwards Pregnancy and Breast Feeding: Malathion (Derbac M) Malathion 0.5% aqueous liquid Leave on for 24 hours. Wash off Apply to the whole body, including the scalp, face, neck and ears. Leave on for 24 hours. Wash off. Repeat after 7 days (unlicensed use see notes in BNF) 200ml* Avoid contact with eyes Do not use on broken or secondarily infected skin Do not use more than once a week for three weeks at a time For children under six months, medical supervision is required Drug Age Dose Quantity Notes, Cautions/Contraindications 12 years Apply to the whole body, including the scalp, face, 100ml onwards neck and ears. Leave on for 24 hours. Wash off If the person requiring treatment has broken skin areas e.g. ulcers, pressure sores, contact a Dermatologist for advice. Avoid contact with eyes Do not use on broken or secondarily infected skin Do not use more than once a week for three weeks at a time Ivermectin (available on a named patient basis from special-order manufacturers or specialist importing companies) in a dose of 200 micrograms/kg by mouth has been used, in combination with topical drugs, for the treatment of Hyperkeratotic Scabies that does not respond to topical treatment alone; further doses of 200 micrograms/kg may be required. Page 14 of 14
STANDARD OPERATING PROCEDURE (SOP) SCABIES POLICY TRANSMISSION BASED PRECAUTIONS.
Page Page 1 of 10 SOP Objective To provide Heath Care Workers (HCWs) with details of the care required to prevent crossinfectionin patients with Scabies.. This SOP applies to all staff employed by NHS
More informationSCABIES PROTOCOL IN WRHA COMMUNITY HEALTH SERVICES CLIENTS AND STAFF
SCABIES PROTOCOL IN WRHA COMMUNITY HEALTH SERVICES CLIENTS AND STAFF Preamble: This algorithm and guideline were developed to assist Community Health Services personnel in managing scabies in the community.
More informationPOLICY FOR THE MANAGEMENT OF CHICKENPOX/SHINGLES
POLICY FOR THE MANAGEMENT OF CHICKENPOX/SHINGLES DOCUMENT CONTROL: Version: 4 Ratified by: Clinical Effectiveness Committee Date ratified: 9 August 2012 Name of originator/author: Infection Prevention
More informationN/A. Director of Nursing and Operations, DIPC. Infection Prevention and Control. IPC Meeting Members
Document Details Title Trust Ref No 782-30737 Local Ref (optional) Main points the document covers Who is the document aimed at? Author Approval process Approved by (Committee/Director) Approval Date 26
More informationAseptic Non-Touch Technique Policy
Aseptic Non-Touch Technique Policy DOCUMENT CONTROL: Version: 4 Ratified by: Quality and Safety Sub Committee Date ratified: 4 July 2016 Name of originator/author: Karen Foltyn, Senior Clinical Nurse Specialist,
More informationManagement of Scabies in Health and Social Care Settings
Management of Scabies in Health and Social Care Settings This information applies to long term care facilities, residential homes and day care centres. Many outbreaks of scabies in long-stay facilities
More informationCARING FOR PATIENTS WITH SUSPECTED OR CONFIRMED PULMONARY TUBERCULOSIS POLICY
CARING FOR PATIENTS WITH SUSPECTED OR CONFIRMED PULMONARY TUBERCULOSIS POLICY DOCUMENT CONTROL: Version: 5 Ratified by: Clinical Quality and Standards Group Date ratified: 5 May 2015 Name of originator/author:
More informationSouth Staffordshire and Shropshire Healthcare NHS Foundation Trust
South Staffordshire and Shropshire Healthcare NHS Foundation Trust 1 Document Version Control Document Type and Title: Authorised Document Folder: Policy for the Management of Parasitic Infestations YELLOW
More informationThe Management of Patients with Scabies policy. Infection Prevention and Control
The Management of Patients with Scabies policy Infection Prevention and Control Description: This policy describes the processes and procedures for the management of patients with known or suspected scabies
More informationPOLICY FOR THE MANAGEMENT OF BLOOD AND BODY FLUID SPILLAGES
POLICY FOR THE MANAGEMENT OF BLOOD AND BODY FLUID SPILLAGES DOCUMENT CONTROL: Version: V61 Ratified by: Clinical Quality and Standards Group Date ratified: 5 May 2015 Name of originator/author: Senior
More informationChecklists for Preventing and Controlling
Checklists for Preventing and Controlling Clostridium difficile Infection (CDI) This document has been developed to specifically assist senior management and all ward staff to take appropriate actions,
More informationProtocol for the Self Administration of Medication within the Locked Rehabilitation and Recovery Inpatient Unit
Protocol for the Self Administration of Medication within the Locked Rehabilitation and Recovery Inpatient Unit DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Assurance Sub Group Date ratified: 28
More informationDeveloped in response to: Best Practice Infection Prevention and Control
Transfer of patients within MEHT Clinical Guideline Developed in response to: Best Practice Infection Prevention and Control Version Number 1.0 Issuing Directorate Corporate Governance Approved by Clinical
More informationPATIENT GROUP DIRECTION
PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% FOR THE TREATMENT OF IMPETIGO BY COMMUNITY PHARMACISTS UNDER THE PHARMACY FIRST SERVICE IN NHS HIGHLAND THE COMMUNITY PHARMACIST SEEKING
More informationSuspected case: Person has clinical features of scabies infestation (See #2 below).
POLICIES & PROCEDURES Number: 55-50 Title: Scabies Outbreak Authorization: X SHR Regional Infection Prevention & Control Committee Source: Infection Prevention & Control Date Initiated: November 2006 Date
More informationHoist and Sling for Safer Patient Use Policy
Hoist and Sling for Safer Patient Use Policy DOCUMENT CONTROL: Version: 4 Ratified by: Quality and Safety Sub Committee Date ratified: 30 January 2017 Name of originator/author: Back Care Advisor Name
More informationGuidelines for In-patient and Residential staff. Staff in Mental Health and Learning Disability In-
Guidelines for In-patient and Residential staff in Mental Health and Learning Disability Services for contacting the On call -Training Grade Doctor/GP DOCUMENT CONTROL Version 4.2 Ratified by Quality and
More informationInfection Prevention and Control (IPC) Standard Operating Procedure for LICE (PEDICULOSIS AND PHTHIRIASIS) in a healthcare setting
Infection Prevention and Control (IPC) Standard Operating Procedure for LICE (PEDICULOSIS AND PHTHIRIASIS) in a healthcare setting WARNING This document is uncontrolled when printed. Check local intranet
More informationHANDLING OF LAUNDRY POLICY
HANDLING OF LAUNDRY POLICY Version: 6 Ratified by: Date ratified: November 2015 Title of originator/author: Title of responsible committee/group: Senior Managers Operational Group Facilities Manager Estates
More informationNHS GREATER GLASGOW & CLYDE CONTROL OF INFECTION COMMITTEE STANDARD OPERATING PROCEDURE (SOP) GROUP A STREPTOCOCCUS (Streptococcus pyogenes)
Page Page 1 of 9 SOP Objective To ensure Healthcare Workers (HCWs) are aware of the actions and precautions necessary to minimise the risk of cross-infection and the importance of diagnosing patients clinical
More informationInfection Control Safety Guidance Document
Infection Control Safety Guidance Document Lead Directorate and Service: Corporate Resources - Human Resources, Safety Services Effective Date: June 2014 Contact Officer/Number Garry Smith / 01482 391110
More informationRESEARCH GOVERNANCE POLICY
RESEARCH GOVERNANCE POLICY DOCUMENT CONTROL: Version: V6 Ratified by: Performance and Assurance Group Date ratified: 12 November 2015 Name of originator/author: Assistant Director of Research Name of responsible
More informationINFECTION CONTROL SURVEILLANCE POLICY
INFECTION CONTROL SURVEILLANCE POLICY Version: 3 Ratified by: Date ratified: July 2016 Title of originator/author: Title of responsible committee/group: Senior Managers Operational Group Head of Infection
More informationTuberculosis (TB) Procedure
Tuberculosis (TB) Procedure (IPC Manual) DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Policies Review and Approval Group Date ratified: 4 September 2018 Name of originator/author: RDaSH Community
More informationClinical Audit Policy
Clinical Audit Policy DOCUMENT CONTROL Version: 5 Ratified by: Quality Assurance Group Date ratified: 3 July 2017 Name of originator/author: Clinical Quality Lead Senior Clinical Audit Facilitator Name
More informationSection 132 of the Mental Health Act 1983 Procedure for Informing Detained Patients of their Legal Rights
Section 132 of the Mental Health Act 1983 Procedure for Informing Detained Patients of their Legal Rights DOCUMENT CONTROL: Version: 11 Ratified by: Mental Health Legislation Sub Committee Date ratified:
More informationLaundry Policy. DOCUMENT CONTROL: Version: 8 Quality Assurance Sub Committee Date ratified: 30 October 2017 Name of
Laundry Policy DOCUMENT CONTROL: Version: 8 Ratified by: Quality Assurance Sub Committee Date ratified: 30 October 2017 Name of Head of Facilities originator/author: Name of responsible Estates Sub Committee
More informationPatient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders.
Patient Group Direction for the supply of Fusidic Acid Cream 2% to patients aged over 2 years old receiving treatment from NHS Borders. This document authorises the supply of Fusidic Acid Cream 2% by registered
More informationPROCEDURE FOR TAKING A WOUND SWAB
CLINICAL PROCEDURE PROCEDURE FOR TAKING A WOUND SWAB Issue History Issue Version Purpose of Issue/Description of Change Planned Review Date 2 To provide a standardised process of the fundamental principles
More informationSECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS (VRE)
SECTION 11.4 VANCOMYCIN RESISTANT ENTERCOCCUS () Introduction Definitions Associated with Risk Groups Signs and Symptoms Source Mode of Transmission Diagnosis Treatment Screening Transport Communication
More informationSCABIES SURVEILLANCE PROTOCOL FOR ONTARIO HOSPITALS
SCABIES SURVEILLANCE PROTOCOL FOR ONTARIO HOSPITALS Developed by the Ontario Hospital Association and the Ontario Medical Association Joint Communicable Diseases Surveillance Protocols Committee Approved
More informationPatient Group Direction For the supply of Fusidic Acid 2% Cream
Patient Group Direction For the supply of Fusidic Acid 2% Cream This Patient Group Direction (PGD) is a specific written instruction for the supply of Fusidic Acid 2% Cream to groups of patients who may
More informationThe most up to date version of this policy can be viewed at the following website:
Page Page 1 of 6 Policy Objective To ensure that HCWs are aware of the actions and precautions necessary to minimise the risk of cross-infection and the importance of diagnosing patients clinical conditions
More informationStandard Precautions for Infection Control
Standard Precautions for Infection Control Author(s) & Designation Lead Clinician if appropriate In consultation with To be read in association with Ratified by Suzanne Golding-Ellis, Head of Patient Safety
More informationClostridium difficile Infection (CDI) in children (3-16 years ) Transmission Based Precautions
Page 1 of 9 Standard Operating procedure (SOP) Objective To provide HCWs with details of the care required to prevent cross-infection in children s with Clostridium difficile Infection (CDI). This SOP
More informationNHS Lothian Patient Group Direction Version: 001
PATIENT GROUP DIRECTION FOR THE SUPPLY OF FUSIDIC ACID CREAM 2% TO TREAT MINOR STAPHYLOCOCCAL SKIN INFECTIONS (IMPETIGO) IN PATIENTS AGED OVER 2 YEARS BY PHARMACISTS WORKING WITHIN NHS LOTHIAN COMMUNITY
More informationMETICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE. Purpose of Issue/Description of Change
METICILLIN RESISTANT STAPHYLOCOCCUS AUREUS (M.R.S.A.) DECOLONISATION GUIDANCE PRIMARY CARE First Issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date 10/2008 1 Guidance
More informationSupply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2
Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 2 Date protocol prepared: October 2017 Date protocol due for review: October 2019 Expiry date: October
More informationBEREWOOD PRIMARY SCHOOL
BEREWOOD PRIMARY SCHOOL Intimate Care Policy February 2015 Revised by School June 2014 Responsible Person Sue Patrick (head teacher) Responsible Committee Full Governing Body Ratified by GB February 2015
More informationProtocol for the Prevention and Management of Clostridium difficile.
Protocol for the Prevention and Management of Clostridium difficile. Policy Profile Policy Reference: Clinical care protocol 14. App D Clin 2.0 Version: Version 2.1 Author: Selma Mehdi, Lead Nurse Infection
More informationInfection Prevention Implementation and adherence to infection prevention practices are the keys to preventing the transmission of infectious diseases
Infection Prevention Infection Prevention Implementation and adherence to infection prevention practices are the keys to preventing the transmission of infectious diseases to yourself, family members,
More informationASEPTIC & CLEAN (NON TOUCH TECHNIQUE) POLICY
ASEPTIC & CLEAN (NON TOUCH TECHNIQUE) POLICY First Issued by/date Issue Version Purpose of Issue/Description of Change Planned Review Date 4 Update September 2012 Named Responsible Officer:- Approved by
More informationPOLICY FOR THE MANAGEMENT OF PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION
POLICY FOR THE MANAGEMENT OF PATIENTS WITH CLOSTRIDIUM DIFFICILE INFECTION DOCUMENT CONTROL: Version: 3 Ratified by: Clinical Effectiveness Committee Date ratified: 9 August 2012 Name of originator/author:
More informationIsolation Care of Patients in Isolation due to Infection or Disease
Infection Prevention and Control Assurance - Standard Operating Procedure 6 (IPC SOP 6) Isolation Care of Patients in Isolation due to Infection or Disease Why we have a procedure? The spread of infection
More informationHand Hygiene Policy. Documentation Control
Documentation Control Reference CL/CGP/039 Approving Body Trust Board Date Approved 3 Implementation date 3 Supersedes NUH Version 2 (May 2009) Consultation undertaken Infection Prevention and Control
More informationIntimate and Personal Care of Children Policy
Coston Primary School Intimate and Personal Care of Children Policy Committee with oversight for this policy Full Governing Body Policy to be signed off by the Full Governing Body Policy last reviewed
More informationRequesting a Second Opinion Policy
Requesting a Second Opinion Policy DOCUMENT CONTROL: Version: 2 Ratified by: Quality and Safety Sub Committee Date ratified: 31 July 201 Name of originator/author: Doncaster Locality Manager, Adult Mental
More informationPreventing Infection in Care
Infection Prevention and Control: Older Person Care Homes & Home Environment Learning Programme Workbook NHS Education for Scotland 2011. You can copy or reproduce the information in this document for
More informationEveryone Involved in providing healthcare should adhere to the principals of infection control.
Infection Control Introduction The prevention and control of infection is an integral part of the role of all health care personnel. Healthcare Associated Infections (HCAIs) affect an estimated one in
More informationSOUTH DARLEY C of E PRIMARY SCHOOL INTIMATE AND PERSONAL CARE POLICY
SOUTH DARLEY C of E PRIMARY SCHOOL INTIMATE AND PERSONAL CARE POLICY Person/Committee responsible for reviewing/updating this plan Premises, Health & Safety Date of Review Governors Meeting Reference Number
More information: Hand. Hygiene Policy NAME. Author: Policy and procedure. Version: V 1.0. Date created: 11/15. Date for revision: 11/18
: Hand NAME Hygiene Policy Target Audience Author: Type: Clinical staff BD Policy and procedure Version: V 1.0 Date created: 11/15 Date for revision: 11/18 Location: Dropbox/website Hand Hygiene Policy
More informationOPERATIONAL POLICY INFECTION PREVENTION AND CONTROL POLICY NO.1
OPERATIONAL POLICY INFECTION PREVENTION AND CONTROL POLICY NO.1 Applies to: All employees of Wirral Community NHS Trust Group for Approval Infection Prevention and Control Group Date of Approval 25 January
More informationPolicy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE)
Policy for the Control and Management of patients Colonised or Infected with Vancomycin resistant enterococci (VRE) Author: Responsible Lead Executive Director: Endorsing Body: Governance or Assurance
More informationabc INFECTION CONTROL STRATEGY
abc INFECTION CONTROL STRATEGY 1. INTRODUCTION East and North Hertfordshire NHS Trust (ENHT) considers the reduction of Healthcare Associated infections (HCAI) a key component of patient safety systems
More informationMedication Policy. Linked to National Quality Standards- Quality Area Two: Element Policy statement
Medication Policy Administering medication should be considered a high risk practice. Authority must be obtained from a parent or legal guardian before educators administer any medication (prescribed or
More informationWest Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan [Updated 19/3/13] Item 37/13
Introduction purpose: West Hertfordshire Hospitals NHS Trust Reducing Clostridium difficile infection Action Plan 2012-2013 [Updated 19/3/13] Item 37/13 This action plan has been developed by West Hertfordshire
More information5.5. The Strawberry Patch Nursery and Pre-school. Illness Policy
Policy statement 5.5 The Strawberry Patch Nursery and Pre-school Illness Policy At The Strawberry Patch we recognise it is our responsibility to ensure the Health and Safety for our children, staff and
More informationHEALTHCARE ASSOCIATED INFECTIONS RISK ASSESSMENT PROCEDURE
HEALTHCARE ASSOCIATED INFECTIONS RISK ASSESSMENT PROCEDURE Author: Jenny Boyce, Lead Infection Prevention & Control Nurse Approved by and date: March 2016 Any other linked ICP 000 - Infection Prevention
More informationLinen Services Policy
Policy No: IC10 Version: 6.0 Name of Policy: Linen Services Policy Effective From: 18/08/2015 Date Ratified 15/07/2015 Ratified Infection Prevention and Control Committee Review Date 01/07/2017 Sponsor
More informationDEFINITION Pinworms are a parasitic infestation of the cecum of the large bowel. It is more common in children.
DEFINITION Pinworms are a parasitic infestation of the cecum of the large bowel. It is more common in children. IMMEDIATE CONSULTATION REQUIRED IN THE FOLLOWING SITUATIONS None CAUSES Enterobius vermicularis
More informationTRUST POLICY AND PROCEDURE FOR THE MANAGEMENT AND CONTROL OF DIARRHOEA AND VOMITING (NOROVIRUS) INFECTIONS
TRUST POLICY AND PROCEDURE FOR THE MANAGEMENT AND CONTROL OF DIARRHOEA AND VOMITING (NOROVIRUS) INFECTIONS Reference Number POL-IC/1079/2011 Old ref no. CL-RM/2014/066 Version 1.2.0 Status Final Author:
More informationThe Newcastle upon Tyne Hospitals NHS Foundation Trust. Animals on Hospital Premises Policy
The Newcastle upon Tyne Hospitals NHS Foundation Trust Animals on Hospital Premises Policy Version No. 6.0 Effective From: 16 March 2018 Expiry Date: 16 March 2021 Date Ratified: 06 March 2018 Ratified
More informationInfection Prevention, Control & Immunizations
Infection Control: This facility task must be used to investigate compliance at F880, F881, and F883. For the purpose of this task, staff includes employees, consultants, contractors, volunteers, and others
More informationPreventing Further Spread of CPE
Provisional Guidance relating to CPE for General Practice. May 26 2017. Issued by the HSE Health Care Associated Infection and Antimicrobial Resistance Response Team. What is CPE (Carbapenemase Producing
More informationPolicy Objective To provide Healthcare Workers with details of the precautions necessary to minimise the risk of RSV cross-infection.
Page Page 1 of 6 Policy Objective To provide Healthcare Workers with details of the precautions necessary to minimise the risk of RSV cross-infection. 1 Responsibilities 2 General information on RSV 3
More informationSHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS 22 FEBRUARY 2012
SHEFFIELD TEACHING HOSPITALS NHS FOUNDATION TRUST EXECUTIVE SUMMARY: BOARD OF DIRECTORS C 22 FEBRUARY 2012 Subject: Supporting : Author: Status (see footnote): Update on the Clostridium difficile (C.diff)
More informationInfection Control and Prevention On-site Review Tool Hospitals
Infection Control and Prevention On-site Review Tool Hospitals Section 1.C. Systems to Prevent Transmission of MDROs Ask these questions of the IP. 1.C.2 Systems are in place to designate patients known
More informationInfection Prevention Control Team
Title Document Type Document Number Version Number Approved by Infection Control Manual Section 3.1 Isolation Precautions and Infection Control Care Plan Policy 3 rd Edition Infection Control Committee
More informationSupply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 version 1
Supply of Fusidic acid 2% cream for impetigo by Community Pharmacists Protocol Number 472 Date protocol prepared: December 2015 Date protocol due for review: December 2017 This patient group direction
More informationPOLICY FOR TAKING BLOOD CULTURES
Sponsor: Reviewer(s): Dr Roberta Parnaby (Consultant Microbiologist) Dr Alicja Baczynska (F2 Microbiology) Dr Chris Gordon (Medical Director) Dr Roberta Parnaby Dr Matthew Dryden (Consultant Microbiologists)
More informationThe Newcastle upon Tyne NHS Hospitals Foundation Trust. Latex Operational Policy
The Newcastle upon Tyne NHS Hospitals Foundation Trust Version No.: 4.2 Effective From: 27 October 2015 Expiry Date: 27 October 2018 Date Ratified: 1 July 2015 Ratified By: Clinical Risk Group 1 Introduction
More informationDecontamination of Medical and Laboratory Equipment Prior to Maintenance or Transportation
Decontamination of Medical and Laboratory Equipment Prior to Maintenance or Transportation Version 4.0 Date to be reviewed January 2020 To be reviewed by Medical Engineering Manager Policy Title: Decontamination
More informationPATIENT IDENTIFICATION POLICY
PATIENT IDENTIFICATION POLICY DOCUMENT CONTROL: Version: 1 Ratified by: Clinical Effectiveness Committee Date ratified: 12 th January 2012 Name of originator/author: Clinical Policy Advisor Name of responsible
More informationAPPROVED CLINICIAN (AC) POLICY FOR MEDICAL STAFF
APPROVED CLINICIAN (AC) POLICY FOR MEDICAL STAFF Version: 1 Ratified by: Date ratified: August 2015 Title of originator/author: Title of responsible committee/group: Date issued: August 2015 Review date:
More informationBest Practice Guidelines BPG 5 Catheter Care
Best Practice Guidelines BPG 5 Catheter Care BGP 5 1 DOCUMENT STATUS: Reviewed DATE ISSUED: March 2014 DATE TO BE REVIEWED: 13.10.17 AMENDMENT HISTORY VERSION DATE AMENDMENT HISTORY V1 March 2014 New Guideline
More informationPrevention and Control of Infection in Care Homes. Infection Prevention and Control Team Public Health Norfolk County Council January 2015
Prevention and Control of Infection in Care Homes Infection Prevention and Control Team Public Health Norfolk County Council January 2015 Content for today Importance of IPAC -refresher IPAC audits in
More informationSafeguarding Children Policy
Safeguarding Children Policy DOCUMENT CONTROL Version: 12.1 Ratified by Quality and Safety Sub Committee Date ratified: 4 September 2017 Name of originator/author: Associate Nurse Director Children s Care
More informationInfection Prevention and Control in Ambulatory Care Settings: Minimum Expectations for Safe Care
Infection Prevention and Control in Ambulatory Care Settings: Minimum Expectations for Safe Care Melissa Schaefer, MD Division of Healthcare Quality Promotion Centers for Disease Control and Prevention
More informationInfection Control Policy
Infection Control Policy Category Summary Policy This policy outlines BAPAM s principles and procedures for infection prevention and control in the clinics environment. It is applicable to all BAPAM personnel
More informationStandard Precautions
Standard Precautions Speciality: Infection Control 1. Indications 1.1 Background Standard Precautions This definition broadens the coverage of the previously known Universal Precautions by recognizing
More informationMRSA. Information for patients Infection Prevention and Control. Large Print
MRSA Information for patients Infection Prevention and Control Large Print page 2 of 16 What is MRSA? MRSA is a bacterium (germ), which can be found living on the skin of healthy individuals, particularly
More informationPulmonary Tuberculosis Policy
Pulmonary Tuberculosis Policy Author: Owner: Publisher: Linda Horton-Fawkes Infection Prevention Team Compliance Unit Date of previous issue: August 2005 Version: 3 Date of version issue: May 2011 Approved
More informationPatient Demographic / Label. Infection Control Care Plan for a patient with MRSA
Patient Demographic / Label Infection Control Care Plan for a patient with MRSA Statement: This Care Plan should be used with patients who are suspected of or are known to have MRSA. This Care Plan should
More informationDate ratified November Review Date November This Policy supersedes the following document which must now be destroyed:
Document Title Reference Number Lead Officer Author(s) (name and designation) Ratified by Cleaning Policy NTW(O)71 James Duncan Deputy Chief Executive / Executive Director of Finance Steve Blackburn Deputy
More informationInspecting Informing Improving. Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust
Inspecting Informing Improving Hygiene code inspection report: West Hertfordshire Hospitals NHS Trust December 2008 Outcome of inspection for: Hospital(s) visited: West Hertfordshire Hospitals NHS Trust
More informationSTAFF DRESS CODE & UNIFORM POLICY
STAFF DRESS CODE & UNIFORM POLICY POLICY REFERENCE NUMBER COR015 DATE RATIFIED (this version) July 2016 NEXT REVIEW DATE July 2019 APPROVED BY (state group) Clinical Policy Steering Group ACCOUNTABLE DIRECTOR
More informationPolicy Number F9 Effective Date: 17/07/2018 Version: 3 Review Date: 17/07/2019
Aim of the Policy This document outlines the policy of Carefound Home Care (the Company ) in relation to infection control. Infection control is the name given to a wide range of policies, procedures and
More informationPediculosis (Head Lice) Management Protocol
Pediculosis (Head Lice) Management Protocol General Information Head lice are tiny insects that live only on the scalp of human beings and are the size of a pinhead. They do not have wings so they cannot
More informationMRSA. Information for patients Infection Prevention and Control
MRSA Information for patients Infection Prevention and Control What is MRSA? MRSA is a bacterium (germ), which can be found living on the skin of healthy individuals, particularly in the lining of the
More informationManaging medicines in care homes
Managing medicines in care homes http://www.nice.org.uk/guidance/sc/sc1.jsp Published: 14 March 2014 Contents What is this guideline about and who is it for?... 5 Purpose of this guideline... 5 Audience
More informationLincolnshire Partnership NHS Foundation Trust (LPFT) Title of Policy
Lincolnshire Partnership NHS Foundation Trust (LPFT) Title of Policy REF: 7n DOCUMENT VERSION CONTROL Document Type and Title: Correct Use of Personal Protective Environment Authorised Document Folder:
More informationCLOSTRIDIUM DIFFICILE ACTION PLAN
CLOSTRIDIUM DIFFICILE ACTION PLAN Action plan to address the rise in cases of Clostridium difficile (C.diff) at Sheffield Teaching Hospitals NHS Foundation Trust ACTION KEY MILESTONES PERSON RESPONSIBLE
More informationAppendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery
Appendix 1: C.diff elements with the Trust s HCAI recovery Plan and Risk to Delivery Issue Action Risk to Year-end trajectory for C difficile infections is 29 cases. Week commencing 09.12.13 - Performance
More informationSection G - Aseptic Technique. Version 5
Section G - Aseptic Technique Version 5 Important: This document can only be considered valid when viewed on the Trust s Intranet. If this document has been printed or saved to another location, you must
More informationPolicy Objective To provide Health Care Workers (HCWs) with details of the precautions necessary to minimise the risk of MRSA cross-infection.
Page 1 of 16 Policy Objective To provide Health Care Workers (HCWs) with details of the precautions necessary to minimise the risk of MRSA cross-infection. This policy applies to all staff employed by
More informationPrevention and control of healthcare-associated infections
Prevention and control of healthcare-associated infections Quality improvement guide Issued: November 2011 NICE public health guidance 36 guidance.nice.org.uk/ph36 NHS Evidence has accredited the process
More informationThe Newcastle Upon Tyne Hospitals NHS Foundation Trust. Standard Precautions Policy
The Newcastle Upon Tyne Hospitals NHS Foundation Trust Version.: 3.2 Effective From: 21 July 2015 Expiry date: 21 July 2018 Date Ratified: 10 July 2015 Ratified By: IPCC 1 Introduction Standard Precautions
More informationVancomycin-Resistant Enterococcus (VRE)
Approved by: Vancomycin-Resistant Enterococcus (VRE) Vice President & Chief Medical Officer Corporate Policy & Procedures Manual VI-40 Date Approved July 14, 2016 August 12, 2016 Next Review (3 years from
More informationCleaning policy. Document author Assured by Review cycle. 1. Introduction Purpose or aim Scope Definitions...
Cleaning policy Board library reference Document author Assured by Review cycle P005 Head of Estates and Facilities Quality and Standards Committee 3 years This document is version controlled. The master
More informationNorth East Ambulance Service NHS Trust Infection Prevention and Control Annual Work Plan April 2009 March 2010 October review (2)
North East Ambulance Service NHS Trust Infection Prevention and Control Annual Work Plan April 2009 March 2010 October review (2) No. Objective Actions Lead Date of 1 Leadership throughout Accountability
More information